HOME >> BIOLOGY >> NEWS
Heat kills inoperable liver tumors without initiating onslaught of harmful hormones

By Melanie Fridl Ross

Gainesville, FL --- The hottest new weapon in the surgeon's arsenal against liver cancer uses heat instead of cold, a shift that could put the freeze on what until now has been the standard therapy for inoperable tumors. What's more, it's easy, cheap and considerably less risky to perform than surgery or using cold to zap malignancies.

Now University of Florida researchers have found that the technique, known as radiofrequency ablation, does not initiate a cascade of harmful hormones that often causes patients who undergo the alternative -- cryotherapy -- to go into shock. Surgeons are scheduled to report the new findings Saturday (2/3) at the annual scientific meeting of the Southeastern Surgical Congress in New Orleans.

"An unfortunate byproduct of cryotherapy is people will develop a form of shock related to the treatment, which has to do with the fact that circulating hormone levels in the body increase and cause a bad systemic reaction, similar to massive overwhelming infection," said Dr. Scott Schell an assistant professor of surgery and of molecular genetics and microbiology at UF's College of Medicine and the UF Shands Cancer Center.

Last summer, the Food and Drug Administration approved the use of radiofrequency ablation, traditionally used to correct heart arrhythmias, for the treatment of liver tumors. For terminally ill liver cancer patients with no other options, the approach offers an alternative that helps slow the disease process, improving their quality of life, Schell said.

"These are patients who basically have no other hope," Schell said. "We are able to help set back the clock using radiofrequency ablation."

Of the estimated 150,000 patients who will be treated for colorectal cancer this year, about half will suffer a recurrence within five years. Less than a third of those people will respond to chemotherapy, and of the tumors that return, most spread to the liver. Chemotherapy doe
'"/>

Contact: Jennifer Guyan
jguyan@vpha.health.ufl.edu
352-392-2621
University of Florida
31-Jan-2001


Page: 1 2 3

Related biology news :

1. An exotic grass kills trees by hijacking their water
2. Cinnamon oil kills mosquitoes
3. Birds show superior listening skills
4. New designed paclitaxel analog kills more cancer cells than natural product
5. UNC study finds protein in male reproductive tract kills bacteria, may improve fertility
6. Fishing kills Fijian coral reefs
7. New paclitaxel analog kills more cancer cells than natural product
8. Toxin combo common in fish appears capable of impairing motor skills
9. Researchers-again-pinpoint why stress kills
10. Technique kills cancerous cells, leaves healthy cells intact
11. New research finds garlic kills slugs

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:9/25/2019)... ... September 25, 2019 , ... LeadingBiotech ... and dialogue, today announces its inaugural South CEO conference to be ... , Co-produced by Tulane University, this invitation-only meeting convenes biopharma executives to ...
(Date:9/24/2019)... ... September 24, 2019 , ... ... interactions for accelerated drug development, announced today that it has raised $2.8M from ... OS Fund and also includes AME Cloud Ventures, Boom Capital, Madrona Venture Group, ...
(Date:9/17/2019)... ... September 17, 2019 , ... Last week, Blackrock Microsystems, ... from the Medical University of Warsaw, met at the Presidential Palace of the ... a neuroprosthetic system as part of an initiative called "Startups in the Palace ...
Breaking Biology News(10 mins):
(Date:9/24/2019)... (PRWEB) , ... September 24, 2019 , ... In the ... for research led by faculty at South Dakota School of Mines & Technology ... tiny microbes that attach to surfaces to form a slimy and yet strong layer ...
(Date:9/17/2019)... ... September 17, 2019 , ... Geneticure, Inc., a ... announces today that the U.S. Patent and Trademark Office (USPTO) and European Patent ... drug class recommendations for hypertension treatment. , The patent applies to Geneticure’s ...
(Date:9/17/2019)... ... 16, 2019 , ... MyBioGate Global Healthcare Innovation Competition Boston ... Boston, a forum organized by MyBioGate, Inc. and CUBIO Innovation Center that promotes ... process of evaluation, twelve companies out of over 200 applications were selected to ...
(Date:9/11/2019)... ... September 10, 2019 , ... ... for drugs, biologics, gene therapies, and consumer health products, today announced that Alex ... at the Bausparkasse Schwäbisch Hall AG, Schwabisch Hall, Germany, on Sept. 18-19, 2019. ...
Breaking Biology Technology:
Cached News: